Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
  1. Home
  2. Stock
  3. NERV
NERV logo

NERV Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Minerva Neurosciences Inc (NERV) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
8.000
1 Day change
33.11%
52 Week Range
12.460
Analysis Updated At
2026/03/06
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Minerva Neurosciences Inc (NERV) is not a strong buy at this moment for a beginner, long-term investor with $50,000-$100,000 to invest. The lack of positive financial performance, absence of trading signals, and no significant catalysts make it prudent to hold off on purchasing this stock right now.

Technical Analysis

The MACD is negatively expanding, indicating bearish momentum. RSI is neutral at 32.483, and moving averages show a bullish crossover (SMA_5 > SMA_20 > SMA_200). However, the pre-market price is down 2.36%, and the stock is trading near its S1 support level of 5.39.

Positive Catalysts

  • NULL identified. No recent news or significant events to drive positive sentiment.

Neutral/Negative Catalysts

  • Pre-market price is down 2.36%. Financial performance shows a significant drop in net income and EPS (-112.19% YoY and -112.12% YoY, respectively). No recent insider or hedge fund activity to indicate confidence in the stock.

Financial Performance

In Q3 2025, revenue remained at 0 with no growth. Net income dropped significantly to -2,743,954 (-112.19% YoY), and EPS fell to -0.36 (-112.12% YoY). Gross margin remains at 0.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No data on analyst ratings or price target changes.

Wall Street analysts forecast NERV stock price to fall
2 Analyst Rating
Wall Street analysts forecast NERV stock price to fall
0 Buy
2 Hold
0 Sell
Hold
Current: 6.010
sliders
Low
4
Averages
4.5
High
5
Current: 6.010
sliders
Low
4
Averages
4.5
High
5
H.C. Wainwright
Neutral
downgrade
$5 -> $4
AI Analysis
2025-11-06
Reason
H.C. Wainwright
Price Target
$5 -> $4
AI Analysis
2025-11-06
downgrade
Neutral
Reason
H.C. Wainwright lowered the firm's price target on Minerva to $4 from $5 and keeps a Neutral rating on the shares. The firm cites equity dilution for the target drop.

People Also Watch